Clinical Trials Browser

Phase 3 × Gastrointestinal Neoplasms × entecavir × Clear all

NCT06966232 2025-05-11

Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers

Phase 3 Recruiting

Gastrointestinal

Gastrointestinal Neoplasms